Literature DB >> 34848887

Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses.

Kazuma Mori1,2, Masato Furuhashi3, Marenao Tanaka1, Yukimura Higashiura1, Masayuki Koyama1,4, Nagisa Hanawa5, Hirofumi Ohnishi1,4.   

Abstract

Whether hyperuricemia is a true risk factor for elevated blood pressure (BP) is controversial, and the sex-specific effects of serum uric acid (SUA) on BP during a follow-up period remain unclear. We investigated whether the association of SUA level with systolic or diastolic BP during a 10-year period differs by sex in a Japanese general population of individuals who received annual health examinations (n = 28,990). After exclusion of subjects who had no BP or SUA data at baseline, a total of 22,994 subjects (male/female: 14,603/8391, age: 47 ± 11 years) were recruited. After adjustment for age; body mass index; BP; SUA level; use of drugs for hyperuricemia and hypertension; diagnosis of diabetes mellitus, dyslipidemia, and chronic kidney disease; family history of hypertension; habits of current smoking and alcohol consumption at baseline; the duration of the observation period; and the interaction between each covariate and the duration of the observation period indicated a significant association of SUA level with change in systolic or diastolic BP over time. There was a significant interaction between sex and SUA level for the change in systolic BP (P = 0.003) but not the change in diastolic BP (P = 0.081). The SUA level at baseline (per 1 mg/dL) was significantly associated with a change in systolic BP over time in females (estimate: 0.073 mmHg/year, P = 0.003) but not in males (estimate: 0.020 mmHg/year, P = 0.160). In conclusion, a high SUA level at baseline is significantly associated with an increase in systolic BP over time in female individuals but not in male individuals.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Blood pressure; Hypertension; Linear mixed-effects model; Sex difference; Uric acid:

Mesh:

Substances:

Year:  2021        PMID: 34848887     DOI: 10.1038/s41440-021-00792-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  59 in total

1.  Gender interaction of uric acid in the development of hypertension.

Authors:  Shinichiro Nishio; Yukio Maruyama; Naoki Sugano; Tatsuo Hosoya; Takashi Yokoo; Satoru Kuriyama
Journal:  Clin Exp Hypertens       Date:  2017-11-28       Impact factor: 1.749

2.  Hyperuricemia and incidence of hypertension among men without metabolic syndrome.

Authors:  Eswar Krishnan; C Kent Kwoh; H Ralph Schumacher; Lewis Kuller
Journal:  Hypertension       Date:  2006-12-26       Impact factor: 10.190

3.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

4.  Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort.

Authors:  Angelo L Gaffo; David R Jacobs; Femke Sijtsma; Cora E Lewis; Ted R Mikuls; Kenneth G Saag
Journal:  Ann Rheum Dis       Date:  2012-09-14       Impact factor: 19.103

Review 5.  New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.

Authors:  Masato Furuhashi
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-09-07       Impact factor: 4.310

Review 6.  High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies.

Authors:  Qin Lv; Xian-Fang Meng; Fang-Fang He; Shan Chen; Hua Su; Jing Xiong; Pan Gao; Xiu-Juan Tian; Jian-She Liu; Zhong-Hua Zhu; Kai Huang; Chun Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 7.  Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies.

Authors:  Ling Li; Chen Yang; Yuliang Zhao; Xiaoxi Zeng; Fang Liu; Ping Fu
Journal:  BMC Nephrol       Date:  2014-07-27       Impact factor: 2.388

Review 8.  Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies.

Authors:  Ji Wang; Tianqiang Qin; Jianrong Chen; Yulin Li; Ling Wang; He Huang; Jing Li
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 9.  Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.

Authors:  Xue Li; Xiangrui Meng; Maria Timofeeva; Ioanna Tzoulaki; Konstantinos K Tsilidis; John PA Ioannidis; Harry Campbell; Evropi Theodoratou
Journal:  BMJ       Date:  2017-06-07

10.  Association between serum uric acid and development of type 2 diabetes.

Authors:  Satoru Kodama; Kazumi Saito; Yoko Yachi; Mihoko Asumi; Ayumi Sugawara; Kumiko Totsuka; Aki Saito; Hirohito Sone
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more
  1 in total

Review 1.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.